AHA Scientific Sessions 2025 Abstract
Proprotein Convertase Subtilisin/ Kexin Type 9 Inhibitors Improve Lipid Profile and May Stabilize Vasculopathy in Heart Transplant Recipients with Chronic Allograft Vasculopathy: A Pooled Analysis of Existing Studies
ReviewInterventions
The paper
Gujranwala Medical College; King Edward Medical University
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4366569


